CrestOptics
Private Company
Total funding raised: $800K
Overview
CrestOptics is a global provider of advanced optical imaging technologies, founded in 2011 and headquartered in Rome, Italy. The company operates a dual business model, serving as an OEM design-in partner for major microscope manufacturers and selling its own branded products, including the X-Light V3 spinning disk confocal and DeepSIM super-resolution system. Its technology focuses on reducing photodamage to enable long-term live-cell imaging, catering to academic, biotech, and pharmaceutical research sectors, as well as expanding into semiconductor metrology and materials science. With a presence in over 50 countries, CrestOptics is positioned as a strategic partner in the high-end microscopy market.
Technology Platform
Optical engineering platform for high-performance, low-phototoxicity microscopy. Core technologies include patented spinning disk confocal designs (X-Light series) for high-speed, gentle live-cell imaging and a versatile, plug-and-play super-resolution Structured Illumination Microscopy (SIM) module (DeepSIM) compatible with standard microscopes.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
CrestOptics operates in a competitive market dominated by large, full-system manufacturers like Zeiss, Leica, Nikon, and Olympus. It differentiates through superior module performance, gentle imaging, and a flexible integration strategy. It also competes with other specialized confocal module providers (e.g., Yokogawa, whose technology is often OEM'd) and super-resolution companies (e.g., Abberior, Gataca Systems for SIM).